v3.26.1
Condensed Consolidated Statements of Cash Flows (Unaudited) - USD ($)
 3 Months Ended 6 Months Ended 12 Months Ended
Jun. 30, 2026
Mar. 31, 2026
Jun. 30, 2025
Mar. 31, 2025
Jun. 30, 2026
Jun. 30, 2025
Dec. 31, 2025
Operating Activities:              
Net loss $ (11,557,002) $ (10,086,687) $ (6,622,563) $ (4,542,528) $ (21,643,689) $ (11,165,091) $ (29,400,000)
Adjustments to reconcile net loss to net cash used in operating activities:              
Stock-based compensation         1,553,705 1,400,608  
Depreciation 90,993   58,494   182,570 96,647  
Amortization of right of use asset         79,080 42,368  
Loss on disposal of fixed assets         34,153  
Realized gain on available-for-sale securities         (49,331)  
Changes in operating assets and liabilities:              
Tax receivable         2,025,564  
Prepaid expenses and other current assets         (854,551) (145,953)  
Accounts payable and accrued expenses         (793,423) 782,904  
Operating lease liability         (71,212) (31,968)  
Net cash used in operating activities         (21,562,698) (6,994,921)  
Investing Activities:              
Purchase of property and equipment         (53,529) (195,343)  
Proceeds from the sale of investments         10,240,000  
Purchase of investments         (12,317,643)  
Net cash used in investing activities         (2,131,172) (195,343)  
Financing Activities:              
Proceeds from sale of common stock under public offering, net of offering costs         140,722,254  
Proceeds from sale of common stock under ATM facility, net of offering costs         14,037,289 1,104,292  
Proceeds from exercise of stock warrants         441,202  
Proceeds from exercise of stock options         44,692 5,824  
Net cash provided by financing activities         155,245,437 1,110,116  
Effect of foreign currency on cash         11,852 36,139  
Net change in cash and cash equivalents         131,563,419 (6,044,009)  
Cash and cash equivalents – beginning of period   $ 93,928,566   $ 17,681,954 93,928,566 17,681,954 17,681,954
Cash and cash equivalents – end of period $ 225,491,985   $ 11,637,945   225,491,985 11,637,945 $ 93,928,566
Supplemental Disclosures of Cash Flow Information:              
Income taxes paid         14,322 18,736  
Supplemental Disclosures of Noncash Financing Information:              
Purchase of property and equipment included in accounts payable and accrued expenses         392,672  
Exercise of cashless warrants         3  
Deferred offering costs charged against proceeds from sale of common stock         93,630 9,893  
Deferred offering costs accrued         120,499  
Shares issues for vested restricted stock awards         $ 16